ClinicalTrials.Veeva

Menu

Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning

N

Nanjing University

Status

Active, not recruiting

Conditions

Diquat Poisoning
Toxic Encephalopathy

Treatments

Procedure: extracorporeal treatment

Study type

Observational

Funder types

Other

Identifiers

NCT06798142
2025-1047-02

Details and patient eligibility

About

This study aims to characterize the relationship between plasma diquat concentrations and organ damage risk.

Enrollment

193 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. history of oral exposure to diquat solution reported by patient or proxy;
  2. a specimen for the diquat plasma concentration collected immediately upon admission;
  3. documentation that patients or, in case of unconsciousness of the patient, legal proxies were aware of and agreed to treatment plans.

Exclusion criteria

  1. they had ingested other toxins in addition to diquat (qualitative toxicological screening tests);
  2. diquat was not detected in specimens, or plasma concentration data were unavailable;
  3. patients with an exposure time (time from exposure to emergency department presentation) longer than 48 hours;
  4. data on organ damage were not unavailable;
  5. combined with other central nervous system injuries other than toxic encephalopathy.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems